Sirius MRI Marker NS
Source, Brachytherapy, Radionuclide. 510(k) K171487, from C4 Imaging, LLC (Doylestown, PA). Product code KXK, class 2.
As of Nov 22, 2026, K171487 is an FDA 510(k) held by C4 Imaging, LLC, substantially equivalent on Aug 25, 2017 after 95 days, with no recalls tied to it in FDA's recall database.
- Review time: 95 days
- Recalls: 0
The Sirius MRI Marker NS is a component device indicated as an accessory for use in conjunction with brachytherapy seed carrier sleeves and radionuclide brachytherapy seeds containing one of the following isotopes: Iodine 125 (125I), Palladium 103 (103Pd) or Cesium 131 (131Cs). It is indicated for permanent interstitial implantation in the prostate of patients with confirmed prostatic malignancy.
- Mri MarkerK131689 · C4 Imaging, LLC · Nov 20, 2013
- OncoPatchK252296 · Oncopatch, Inc. · Dec 5, 2025
- IsoSphereK242818 · Isoaid, LLC · Jul 15, 2025
- RadianceTx Radionuclide Brachytherapy SourceK223465 · Radiance Therapeutics, Inc. · Jan 11, 2023
- GammaTileK221539 · Gt Medical Technologies · Nov 9, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 22, 2017
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5730
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files